|
Volumn 359, Issue 6379, 2018, Pages 1037-1042
|
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOKINE RECEPTOR;
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR ALPHA;
INTERLEUKIN 2 RECEPTOR BETA;
INTERLEUKIN 2 RECEPTOR GAMMA;
PROGRAMMED DEATH 1 RECEPTOR;
STAT5 PROTEIN;
INTERLEUKIN 2 RECEPTOR;
BIOENGINEERING;
CANCER;
CELL;
IMMUNE RESPONSE;
PLEIOTROPY;
PROTEIN;
TOXICITY;
ADOPTIVE IMMUNOTHERAPY;
ADOPTIVE TRANSFER;
ANIMAL MODEL;
ANTIGEN EXPRESSION;
ARTICLE;
BINDING AFFINITY;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL ENGINEERING;
CELL EXPANSION;
CELL FUNCTION;
CELL SURVIVAL;
CELL TRANSFER;
CELLULAR IMMUNITY;
CONTROLLED STUDY;
CRYSTAL STRUCTURE;
CYTOKINE PRODUCTION;
GENOTYPE;
IMMUNOSTIMULATION;
MOUSE;
NONHUMAN;
PHENOTYPE;
PLEIOTROPY;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
REGULATORY T LYMPHOCYTE;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE;
TUMOR IMMUNITY;
ANIMAL;
EXPERIMENTAL MELANOMA;
GENETICS;
HEK293 CELL LINE;
HUMAN;
IMMUNOLOGY;
NEOPLASM;
PROCEDURES;
ANIMALS;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
CELL ENGINEERING;
HEK293 CELLS;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
MELANOMA, EXPERIMENTAL;
MICE;
NEOPLASMS;
RECEPTORS, INTERLEUKIN-2;
|
EID: 85042829852
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aar3246 Document Type: Article |
Times cited : (260)
|
References (28)
|